Granite Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Granite Investment Advisors's BMY Position: Q3 2021 in Review
Granite Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.9% in Q3 2021, selling an estimated $139K and leaving 109,557 shares worth $6.48M. The position accounts for 1.05% of the portfolio, ranked #26.
Granite Investment Advisors first reported a position in BMY in Q3 2017 and has held it in 12 quarters since. The position peaked at $10M in Q1 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Granite Investment Advisors held 109,557 shares of Bristol-Myers Squibb worth $6.48M as of Q3 2021.
- Granite Investment Advisors sold 2,106 Bristol-Myers Squibb shares in Q3 2021, an estimated $139K.
- Bristol-Myers Squibb made up 1.05% of Granite Investment Advisors's portfolio in Q3 2021, its #26 holding.
- Granite Investment Advisors first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 12 quarters since.
- Granite Investment Advisors's Bristol-Myers Squibb position peaked at $10M in Q1 2021.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Granite Investment Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.